At LogiPharma USA 2026, Cold Chain Technologies' TJ Rizzo explains how gaps in end-to-end cold chain expertise create risk for advanced therapies.
Publication|Articles|December 17, 2025
- Pharmaceutical Commerce - December 2025
- Volume 20
- Issue 6
Pharmaceutical Commerce: December 2025 Interactive Digital Edition
View the Pharmaceutical Commerce December 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
10 months ago
The Market Access Terrain10 months ago
Finishing Strong While Looking Ahead10 months ago
The Next Era of Drug Safety is in Intelligent Action10 months ago
Working with the MiddleAdvertisement
Related to this article
Octapharma USA's Kerem Tokel explains how tariffs and DSCSA are affecting how stolen pharma loads are resold, and why partner SOPs matter.
At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.
PhRMA's lawsuit argues CMS overstepped its demonstration authority by tying Medicare Part B rebates to international prices.
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.
At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: PhRMA Sues to Block GLOBE Model and Bayer's $2.2B Ohio Site
2
LogiPharma USA 2026: Data Readiness Must Come Before AI
3
LogiPharma USA 2026: Where Cold Chain Expertise Gaps Become Product Risk
4
Why PhRMA Sued to Block Medicare's GLOBE Pricing Model
5